dr. kolberg on collecting real-world biosimilar trastuzumab data in breast cancer
Published 4 years ago • 138 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:27
dr. kolberg on the safety profile of trastuzumab biosimilars in breast cancer
-
1:56
dr. kolberg on the lilac study in breast cancer
-
3:14
abp 980, a trastuzumab biosimilar in combination with pertuzumab
-
1:51
dr. kolberg on cost-effectiveness of pertuzumab in her2-positive breast cancer
-
3:38
biosimilar trastuzumab
-
0:51
dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
2:17
dr. kolberg explains the approval process for biosimilars
-
1:30
dr. hope rugo on trastuzumab biosimilar in her2-positive breast cancer
-
1:12
dr. esteva on trastuzumab biosimilar in breast cancer
-
5:09
the use of biosimilars in her2 breast cancer
-
1:49
dr. esteva on trastuzumab biosimilar in patients with her2 breast cancer
-
12:12
breast cancer treatment - trastuzumab biosimilars
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
1:40
dr. esteva on clinical trial design of trastuzumab biosimilar in her2 breast cancer
-
2:07
dr. esteva on the trastuzumab biosimilar candidate ct-p6 in her2 breast cancer
-
1:00
dr. slamon on the use of trastuzumab and bevacizumab biosimilars in breast cancer
-
0:43
dr. kalinsky discusses biosimilars in breast cancer